- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
August 14th, 2007
Promising new nanomedical cancer therapy also highlights tech transfer
If a new approach to cancer therapy, still experimental and in a phase I clinical trial, turns out as well as hoped, the credit will go as much to technology transfer as to scientific acumen.
That's the opinion of Mark Davis, the Schlinger Professor of Chemical Engineering at the California Institute of Technology. Davis's custom-designed nanoparticles for fighting cancer are currently being tested on patients at City of Hope in nearby Duarte, and are now in the planning stages for more extensive phase II trials. The nanoparticles are built to deliver chemotherapy drugs to tumors in such a way that the adverse effects of the drugs on the rest of the body are minimized.
|Related News Press|
Stretching the limits on conducting wires July 25th, 2015
Nanopaper as an optical sensing platform July 23rd, 2015